Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Oct;63(10):4170–4173. doi: 10.1128/iai.63.10.4170-4173.1995

Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans.

M Puliti 1, D Radzioch 1, R Mazzolla 1, R Barluzzi 1, F Bistoni 1, E Blasi 1
PMCID: PMC173587  PMID: 7558336

Abstract

The Bcg/Ity/Lsh gene (candidate Nramp) controls natural resistance to several parasites, such as Mycobacterium bovis, Leishmania donovani, and Salmonella typhimurium. Using two macrophage (M phi) cell lines (B10R and B10S) derived from mouse strains congenic at Bcg, we found that M phi s from resistant mice (B10R M phi s) act more effectively against the two morphogenetic forms of the dimorphic fungus Candida albicans compared with M phi s from susceptible mice (B10S M phi s). Moreover, when assessed for tumor necrosis factor secretion in response to the hyphal form of C. albicans, B10R M phi s are significantly more effective at expressing this secretory function than are B10S M phi s, closely resembling the trend of response to lipopolysaccharide. Overall, these results provide insight into the influence of the Bcg locus on the M phi response to C. albicans.

Full Text

The Full Text of this article is available as a PDF (228.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton C. H., White J. K., Roach T. I., Blackwell J. M. NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J Exp Med. 1994 May 1;179(5):1683–1687. doi: 10.1084/jem.179.5.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blackwell J. M., Roach T. I., Atkinson S. E., Ajioka J. W., Barton C. H., Shaw M. A. Genetic regulation of macrophage priming/activation: the Lsh gene story. Immunol Lett. 1991 Oct;30(2):241–248. doi: 10.1016/0165-2478(91)90032-6. [DOI] [PubMed] [Google Scholar]
  3. Blasi E., Farinelli S., Varesio L., Bistoni F. Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun. 1990 Apr;58(4):1073–1077. doi: 10.1128/iai.58.4.1073-1077.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blasi E., Pitzurra L., Puliti M., Bartoli A., Bistoni F. Candida albicans hyphal form enhances tumor necrosis factor mRNA levels and protein secretion in murine ANA-1 macrophages. Cell Immunol. 1992 Jun;142(1):137–144. doi: 10.1016/0008-8749(92)90275-t. [DOI] [PubMed] [Google Scholar]
  5. Blasi E., Pitzurra L., Puliti M., Lanfrancone L., Bistoni F. Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun. 1992 Mar;60(3):832–837. doi: 10.1128/iai.60.3.832-837.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Booker G. W., Gout I., Downing A. K., Driscoll P. C., Boyd J., Waterfield M. D., Campbell I. D. Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell. 1993 May 21;73(4):813–822. doi: 10.1016/0092-8674(93)90259-s. [DOI] [PubMed] [Google Scholar]
  7. Bradley D. J. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin Exp Immunol. 1977 Oct;30(1):130–140. [PMC free article] [PubMed] [Google Scholar]
  8. Brummer E., Morrison C. J., Stevens D. A. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun. 1985 Sep;49(3):724–730. doi: 10.1128/iai.49.3.724-730.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Buschman E., Taniyama T., Nakamura R., Skamene E. Functional expression of the Bcg gene in macrophages. Res Immunol. 1989 Oct;140(8):793–797. doi: 10.1016/0923-2494(89)90035-7. [DOI] [PubMed] [Google Scholar]
  10. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol. 1993 May;23(5):1034–1038. doi: 10.1002/eji.1830230508. [DOI] [PubMed] [Google Scholar]
  11. English B. K., Ihle J. N., Myracle A., Yi T. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J Exp Med. 1993 Sep 1;178(3):1017–1022. doi: 10.1084/jem.178.3.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Formica S., Roach T. I., Blackwell J. M. Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. Immunology. 1994 May;82(1):42–50. [PMC free article] [PubMed] [Google Scholar]
  13. Gros P., Skamene E., Forget A. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J Immunol. 1983 Oct;131(4):1966–1972. [PubMed] [Google Scholar]
  14. Gros P., Skamene E., Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol. 1981 Dec;127(6):2417–2421. [PubMed] [Google Scholar]
  15. Levitz S. M., Diamond R. D. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis. 1985 Nov;152(5):938–945. doi: 10.1093/infdis/152.5.938. [DOI] [PubMed] [Google Scholar]
  16. Lissner C. R., Swanson R. N., O'Brien A. D. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol. 1983 Dec;131(6):3006–3013. [PubMed] [Google Scholar]
  17. Louie A., Baltch A. L., Smith R. P., Franke M. A., Ritz W. J., Singh J. K., Gordon M. A. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun. 1994 Jul;62(7):2761–2772. doi: 10.1128/iai.62.7.2761-2772.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mayer B. J., Baltimore D. Signalling through SH2 and SH3 domains. Trends Cell Biol. 1993 Jan;3(1):8–13. doi: 10.1016/0962-8924(93)90194-6. [DOI] [PubMed] [Google Scholar]
  19. Plant J., Glynn A. A. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis. 1976 Jan;133(1):72–78. doi: 10.1093/infdis/133.1.72. [DOI] [PubMed] [Google Scholar]
  20. Radzioch D., Hudson T., Boulé M., Barrera L., Urbance J. W., Varesio L., Skamene E. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol. 1991 Sep;50(3):263–272. doi: 10.1002/jlb.50.3.263. [DOI] [PubMed] [Google Scholar]
  21. Ramarathinam L., Niesel D. W., Klimpel G. R. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium. J Immunol. 1993 May 1;150(9):3965–3972. [PubMed] [Google Scholar]
  22. Roach T. I., Chatterjee D., Blackwell J. M. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun. 1994 Apr;62(4):1176–1184. doi: 10.1128/iai.62.4.1176-1184.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rubin B. Y., Anderson S. L., Sullivan S. A., Williamson B. D., Carswell E. A., Old L. J. Purification and characterization of a human tumor necrosis factor from the LuKII cell line. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6637–6641. doi: 10.1073/pnas.82.19.6637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ruoslahti E. Integrins. J Clin Invest. 1991 Jan;87(1):1–5. doi: 10.1172/JCI114957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Scaringi L., Blasi E., Cornacchione P., Bietta C., Bistoni F. A rapid Candida albicans hyphal-form growth inhibition assay: determination of myelomonocytic-mediated antifungal activity. Mycoses. 1991 Mar-Apr;34(3-4):119–123. doi: 10.1111/j.1439-0507.1991.tb00631.x. [DOI] [PubMed] [Google Scholar]
  26. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  27. Skamene E. Genetic control of resistance to mycobacterial infection. Curr Top Microbiol Immunol. 1986;124:49–66. doi: 10.1007/978-3-642-70986-9_4. [DOI] [PubMed] [Google Scholar]
  28. Skamene E., Gros P., Forget A., Kongshavn P. A., St Charles C., Taylor B. A. Genetic regulation of resistance to intracellular pathogens. Nature. 1982 Jun 10;297(5866):506–509. doi: 10.1038/297506a0. [DOI] [PubMed] [Google Scholar]
  29. Skamene E., Pietrangeli C. E. Genetics of the immune response to infectious pathogens. Curr Opin Immunol. 1991 Aug;3(4):511–517. doi: 10.1016/0952-7915(91)90013-q. [DOI] [PubMed] [Google Scholar]
  30. Stach J. L., Gros P., Forget A., Skamene E. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol. 1984 Feb;132(2):888–892. [PubMed] [Google Scholar]
  31. Van 't Wout J. W., Meynaar I., Linde I., Poell R., Mattie H., Van Furth R. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages. J Antimicrob Chemother. 1990 May;25(5):803–811. doi: 10.1093/jac/25.5.803. [DOI] [PubMed] [Google Scholar]
  32. Vidal S. M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 1993 May 7;73(3):469–485. doi: 10.1016/0092-8674(93)90135-d. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES